Study number 8525-798
Dates
May 07 2024-May 30 2024
Location
Madison, Wisconsin
Age
18-60
Gender
Females of Non-Childbearing Potential and Males
Compensation
$6,500
Group
B4
This is a research study for an investigational drug being developed for the treatment of epilepsy and other neurological conditions. The study drug is already a licensed drug in the United States, European Union and United Kingdom. The use of the study drug for the purposes of this study has not been approved by the United States Food and Drug Administration (FDA).
Fortrea Madison, WI is recruiting for:
- Healthy Men and Women of Non-Childbearing Potential, age 18-60
- Body Mass Index between 18.5-30
- Study involves 1 stay of 11 nights, plus 2 follow-up visits
- Compensation up to $6,500 may be provided for time and participation
- Refer a friend to receive up to $500 per qualified referral
Group B4:
Check-In: May 7
Check-Out: May 18
Outpatient Visits: May 23, 30
The last day to screen for this study is May 1